Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Badu, Kingsley ^a,b   Siangla, Joram ^c   Larbi, John ^a   Lawson, Bernard W ^a   Afrane, Yaw ^b   Ong'Echa, John ^b   Remoue, Franck ^d   Zhou, Guofa ^e   Githeko, Andrew K ^b   Yan, Guiyun ^e  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c U S ARMY   (United States)

^d UNIV MONTPELLIER   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GSG6 P1 PROTEIN; SALIVA PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANOPHELES GAMBIAE; ANTIBODY RESPONSE; ARTICLE; CHILD; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENDEMIC DISEASE; GROUPS BY AGE; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA; PARASITE PREVALENCE; PRESCHOOL CHILD; SALIVA ANALYSIS; SCHOOL CHILD; SEASONAL VARIATION; SEROPREVALENCE;

ANIMALS; ANOPHELES GAMBIAE; ANTIBODIES, PROTOZOAN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGICAL MONITORING; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; INSECT PROTEINS; INSECT VECTORS; KENYA; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; SALIVARY PROTEINS AND PEPTIDES; SEASONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84865846718     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-318     Document Type: Article

References (44)

1. Changing pattern of malaria in Bissau, Guinea Bissau. Rodrigues A, Schellenberg JA, Kofoed PE, Aaby P, Greenwood B, Trop Med Int Health 2008 13 410 417 10.1111/j.1365-3156.2008.02016.x 18298608
2. Changes in the burden of malaria in sub-Saharan Africa. O'Meara WP, Mangeni JN, Steketee R, Greenwood B, Lancet Infect Dis 2010 10 545 555 10.1016/S1473-3099(10)70096-7 20637696
3. World Health Organization, WHO World Malaria Report Geneva, Switzerland 2009
4. Malaria incidence and prevalence on Pemba Island before the onset of the successful control intervention on the Zanzibar archipelago. Jaenisch T, Sullivan DJ, Dutta A, Deb S, Ramsan M, Othman MK, Gaczkowski R, Tielsch J, Sazawal S, Malar J 2010 9 32 10.1186/1475-2875-9-32 20100352
5. A progressive declining in the burden of malaria in north-eastern Tanzania. Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP, Malar J 2010 9 216 10.1186/1475-2875-9-216 20650014
6. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Marsh K, Lancet 2008 372 1555 1562 10.1016/S0140-6736(08)61655-4 18984188
7. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJC, Sesay SSS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ, Lancet 2008 372 1545 1554 10.1016/S0140-6736(08)61654-2 18984187
8. Scaling up malaria control in Zambia: progress and impact 2005-2008. Chizema-Kawesha E, Miller JM, Steketee RW, Mukonka VM, Mukuka C, Mohamed AD, Miti SK, Campbell CC, Am J Trop Med Hyg 2010 83 480 488 10.4269/ajtmh.2010.10- 0035 20810807
9. A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa. Kunene S, Phillips AA, Gosling RD, Kandula D, Novotny JM, Malar J 2011 10 313 10.1186/1475-2875-10-313 22018266
10. World Health Organization, WHO World Malaria Report Geneva, Switzerland 2011
11. Is the current decline in malaria burden in sub-Saharan Africa due to a decrease in vector population? Meyrowitsch DW, Pedersen EM, Alifrangis M, Scheike TH, Malecela MN, Magesa SM, Derua YA, Rwegoshora RT, Michael E, Simonsen PE, Malar J 2011 10 188 10.1186/1475-2875-10-188 21752273
12. The limits and intensity of Plasmodium falciparum transmission: Implications for malaria control and elimination worldwide. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW, PLoS Med 2008 5 38 10.1371/journal.pmed.0050038 18303939
13. Control to elimination: Implication for malaria research. Greenwood BM, Trends Parasitol 2008 24 449 454 10.1016/j.pt.2008.07.002 18760671
14. Acquired Immunity to Malaria. Doolan DL, Dobaño C, Baird JK, Clin Microbiol Rev 2009 22 13 36 10.1128/CMR.00025-08 19136431
15. Impact of the malaria control campaign (1993-1998) in the highlands of Madagascar: parasitological and entomological data. Romi R, Razaiarimanga MC, Raharimanga R, Rakotondraibe EM, Ranaivo LH, Pietra V, Raveloson A, Majori G, Am J Trop Med Hyg 2002 66 2 6 12135262
16. MacDonald G, The epidemiology and control of malaria London: Oxford University Press 1957
17. A research agenda for malaria eradication: monitoring, evaluation, and surveillance. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance, PLoS Med 2011 8 e1000400
18. Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. Smith T, Killeen G, Lengeler C, Tanner M, Am J Trop Med Hyg 2004 71 80 86 15331822
19. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, Noor AM, Snow RW, Drakeley C, Emerg Infect Dis 2010 16 392 399 10.3201/eid1603.090732 20202412
20. Using serological measures to monitor changes in malaria transmission in Vanuatu. Cook J, Reid H, Lavro J, Kuwahata, Taleo G, Clements A, McCarthy J, Vallely A, Drakeley C, Malar J 2010 9 169 10.1186/1475-2875-9-169 20553604
21. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, Cisse B, Sokhna C, Arcà B, Simondon F, Remoue F, PLoS One 2008 3 2472 10.1371/journal.pone.0002472 18575604
22. Serology: a robust indicator of malaria transmission intensity? Corran P, Coleman P, Riley E, Drakeley C, Trends Parasitol 2007 23 575 582 10.1016/j.pt.2007.08.023 17988945
23. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Malima R, Lusingu J, Manjurano A, Nkya WMM, Lemnge MM, Cox J, Reyburn H, Riley EM, Proc Natl Acad Sci U S A 2005 102 5108 5113 10.1073/pnas.0408725102 15792998
24. Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. Badu K, Afrane YA, Larbi J, Stewart VN, Waitumbi J, Angov E, Ong'echa JM, Perkins DJ, Zhou G, Githeko A, Yan G, BMC Infect Dis 2012 12 50 10.1186/1471-2334-12-50 22380785
25. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F, Simondon F, Carnevale P, Remoue F, PLoS One 2010 5 15596 10.1371/journal.pone.0015596 21179476
26. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, Boulanger D, Simondon F, Trans R Soc Trop Med Hyg 2006 100 363 370 10.1016/j.trstmh.2005.06.032 16310235
27. Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Waitayakul A, Somsri S, Sattabongkot J, Looareesuwan S, Cui L, Udomsangpetch R, Acta Trop 2006 98 66 73 10.1016/j.actatropica.2006.02. 004 16530153
28. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M, Sokhna C, Cisse B, Simondon F, Remoue F, Malar J 2009 8 198 10.1186/1475-2875-8-198 19674487
29. Humoral response to the Anopheles gambiae salivary protein gSG6: A serological indicator of exposure to Afrotropical malaria vectors. Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, Poinsignon A, Sirima SB, Nèbiè I, Lombardo F, Remoue F, Coluzzi M, Petrarca V, Modiano D, Arcà B, PLoS One 2011 6 17980 10.1371/journal.pone.0017980 21437289
30. Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Orlandi-Pradines E, Almeras L, Denis de Senneville L, Barbe S, Remoué F, Villard C, Cornelie S, Penhoat K, Pascual A, Bourgouin C, Fontenille D, Bonnet J, Corre-Catelin N, Reiter P, Pagés F, Laffite D, Boulanger D, Simondon F, Pradines B, Fusaï T, Rogier C, Microbes Infect 2007 9 1454 1462 10.1016/j.micinf.2007.07.012 17913537
31. Advances in the study of Afrotropical malaria vectors. Coluzzi M, Parassitologia 1993 35 23 29 Suppl 8233606
32. First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites. Poinsignon A, Samb B, Doucoure S, Drame PM, Sarr JB, Sow C, Cornelie S, Maiga S, Thiam C, Rogerie F, Guindo S, Hermann E, Simondon F, Dia I, Riveau G, Konate L, Remoue F, Trop Med Int Health 2010 15 1198 1203 10.1111/j.1365-3156. 2010.02611.x 20723184
33. Topography and malaria transmission heterogeneity in western Kenya highlands: prospects for focal vector control. Githeko AK, Ayisi JM, Odada PK, Atieli FK, Ndenga BA, Githure JI, Yan G, Malar J 2006 5 107 10.1186/1475-2875-5- 107 17096835
34. Plasmodium falciparum spatial analysis, Western Kenya highlands. Munyekenye OG, Githeko AK, Zhou G, Mushinzimana E, Minakawa N, Yan G, Emerg Infect Dis 2005 11 1571 1577 10.3201/eid1110.050106 16318698
35. Population dynamics of malaria vectors in western Kenya highlands. Ndenga B, Githeko AK, Omukunda E, Munyekenye G, Atieli H, Wamae P, Mbogo C, Minakawa N, Zhou G, Yan G, J Med Entomol 2006 43 200 206 10.1603/0022-2585(2006)043[0200: PDOMVI]2.0.CO;2 16619599
36. Changing Patterns of Malaria Epidemiology between 2002 and 2010 in Western Kenya: The Fall and Rise of Malaria. Zhou G, Afrane YA, Vardo-Zalik AM, Atieli H, Zhong D, Wamae P, Yousif EH, Minakawa N, Githeko AK, Yan G, PLoS One 2011 6 20318 10.1371/journal.pone.0020318 21629783
37. The dissipation of hexazinone in tropical soils under semi-controlled field conditions in Kenya. Lalah JO, Muendo BM, Getenga ZM, J Environmental Sci Health: Part B 2009 44 690 696 10.1080/03601230903163772
38. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Burghaus PA, Holder AA, Mol Biochem Parasitol 1994 64 165 169 10.1016/0166-6851(94)90144-9 8078519
39. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia col protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA, Infect Immun 2005 73 287 297 10.1128/IAI.73.1.287-297.2005 15618165
40. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Drakeley C, Cook J, In Advances in Parasitology69 Burlington: Academic, David R, Simon Iain H, 2009 299
41. Habitat characteristics of Anopheles gambiae s. s. larvae in a Kenyan highland. Minakawa N, Sonye G, Mogi M, Yan G, Med Vet Entomol 2004 18 301 305 10.1111/j.0269-283X.2004.00503.x 15347399
42. Population dynamics of mosquito-borne disease: effects of flies which bite some people more frequently than others. Dye C, Hasibeder G, Trans R Soc Trop Med Hyg 1986 80 69 77 10.1016/0035-9203(86)90199-9 3727001
43. The entomological inoculation rate and Plasmodium falciparum infection in African children. Smith DL, Dushoff J, Snow RW, Hay SI, Nature 2005 438 492 495 10.1038/nature04024 16306991
44. Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Andrade BB, Rocha BC, Reis-Filho A, Camargo LM, Tadei WP, Mo-reira LA, Barral A, Barral-Netto M, Malar J 2009 8 121 10.1186/1475-2875-8-121 19500362